Avian Cholera (Fowl Cholera): A Comprehensive Veterinary Reference

Introduction

Avian cholera, also termed fowl cholera, is a contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [1, 2]. The disease manifests in peracute, acute, or chronic forms and is associated with high morbidity and mortality, particularly in waterfowl, turkeys, and chickens [3, 2, 4]. Understanding the biological mechanisms of P. multocida pathogenesis and host interactions is essential for effective diagnosis, treatment, and control [1, 5]. This article provides a detailed veterinary reference on fowl cholera bacterial characteristics, clinical disease, diagnostic approaches, and management strategies, integrating recent genomic and immunological findings.

Etiology and fowl cholera bacterial characteristics

Pasteurella multocida is a Gram-negative, nonmotile, facultatively anaerobic coccobacillus belonging to the family Pasteurellaceae [6, 7]. The bacterium is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic serotypes, with serogroup A being most commonly associated with avian fowl cholera [8, 9]. Lipopolysaccharide (LPS) outer core loci exhibit phase variation, contributing to immune evasion and outbreak persistence on free-range layer farms [9]. Complete genome sequences of multiple isolates representing all LPS outer core loci have been published, facilitating comparative genomic analyses [7]. In India, fowl cholera (referred to as fowl cholera in Hindi literature) remains a significant constraint to poultry production, with multidrug-resistant type B:2 strains reported in Bangladesh [10] and widespread ST20 clones detected in Australian poultry farms [11].

Virulence factors

P. multocida possesses an array of virulence determinants, including capsular polysaccharides, LPS, adhesins, and secreted toxins [6, 12]. The filamentous hemagglutinin B1 (FhaB1) gene, however, is not involved in avian fowl cholera pathogenesis in turkey poults [13]. The hyaD gene contributes to virulence by modulating hyaluronic acid capsule synthesis [12]. In ducks, P. multocida causes liver injury through inflammatory, apoptotic, and autophagic pathways [5], while in broilers, liver pyroptosis is mediated via the MAPK-NLRP3-GSDMD signaling pathway [1]. These findings underscore the species-specific molecular pathogenesis of avian pasteurellosis.

Epidemiology

Avian cholera occurs worldwide and affects a broad range of avian hosts, including chickens, turkeys, ducks, geese, and wild birds such as yellow-eyed penguins [4, 11]. Transmission occurs primarily through direct contact with infected birds, contaminated feed and water, or fomites [14]. The bacterium can survive in the environment for weeks under favorable conditions, and carrier birds are important reservoirs [14, 11]. Outbreaks are often precipitated by stress factors such as overcrowding, poor ventilation, or concurrent infections [3, 2].

A compartmental model of cholera transmission in poultry farms has provided insights into disease dynamics and control strategies [14]. Coinfection with Mycoplasmoides gallisepticum has been reported to increase mortality in commercial turkey flocks [3]. In Morocco, an outbreak in turkeys caused by P. multocida serogroup A was characterized by acute mortality [8]. Strikingly, 100% mortality in commercial slow-growing broilers with acute fowl cholera has been documented [2].

Clinical signs

Clinical presentation depends on the disease form. Peracute infections cause sudden death with minimal premonitory signs [2, 4]. Acute avian cholera is characterized by fever, anorexia, depression, mucoid discharge from the mouth and nostrils, increased respiratory rate, cyanosis of the comb and wattles, and diarrhea [3, 2]. Chronic infections may present with localized swellings of the wattles, joints, foot pads, and sinuses [8, 4]. In turkeys, coinfection with Mycoplasma gallisepticum exacerbates respiratory signs [3].

Pathology

Gross lesions in acute fowl cholera include diffuse congestion and petechial hemorrhages on the heart, liver, and serosal surfaces [2, 5]. The liver often shows multiple focal necrotic foci [1, 5]. Pneumonia and airsacculitis are common, especially in turkeys [3, 8]. Microscopically, hepatic pyroptosis and inflammatory infiltration are prominent [1]. In ducks, liver injury involves hepatocellular apoptosis and autophagic vacuolization [5]. Chronic cases exhibit caseous or purulent exudate in wattles and joint cavities [8, 4].

Diagnostics

Definitive diagnosis of fowl cholera relies on bacterial isolation and identification of P. multocida from blood, liver, spleen, or bone marrow [8, 15]. Molecular methods have largely replaced traditional biochemical typing. A comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays demonstrated high sensitivity and specificity for detecting P. multocida in poultry [16]. An in-house indirect ELISA kit has been developed and optimized for detection of anti-P. multocida antibodies in chickens [17]. Whole-genome sequencing provides detailed information on serotype, antimicrobial resistance genes, and phylogenetic relationships [7, 18].

Diagnostic workflow

Below is a Mermaid diagram representing a typical decision tree for laboratory diagnosis of avian cholera.

graph TD
    A[Clinical suspect: acute mortality, lesions], > B{Postmortem samples}
    B, > C[Blood smear / impression smear: bipolar staining]
    B, > D[Culture on blood agar / MacConkey]
    D, > E{Growth: Gram-negative coccobacilli}
    E, > F[Biochemical confirmation: oxidase +, catalase +, indole +]
    F, > G[Molecular detection: PCR / LAMP / sequencing]
    G, > H[Serotyping: capsular PCR / LPS genotyping]
    H, > I[Antimicrobial susceptibility testing]
    B, > J[Histopathology: liver necrosis, pyroptosis]
    I, > K[Report and control recommendations]

Treatment

Antimicrobial therapy remains the cornerstone of treatment for acute outbreaks, but increasing resistance necessitates susceptibility testing [19, 6, 10]. Multidrug resistance in avian P. multocida isolates has been documented globally, with resistance genes such as blaROB-1, tet, and sul commonly identified [19, 6]. Bacteriophage therapy using phage vB_PmuM_CFP3 has shown potential for biocontrol of avian P. multocida [20]. Natural products such as Egyptian artichoke extract have demonstrated in vitro anti-P. multocida activity [21]. Multi-strain probiotics have been reported to reduce fowl cholera mortality in broilers [22].

Control

Biosecurity and management

Strict biosecurity measures, including all-in-all-out production, cleaning and disinfection, and control of rodents and wild birds, are essential to prevent introduction and spread of P. multocida [14, 2]. Vaccination is a key component of long-term control, especially in endemic areas.

Vaccination

Both inactivated bacterins and live attenuated vaccines are used. Gamma-irradiated vaccines formulated with various adjuvants induce robust antibody responses and cytokine expression in chickens [23, 24]. A gel 01 hydrogel inactivated vaccine provided immunoprotection against P. multocida infection in chickens [25]. In Morocco, an autogenous inactivated vaccine prepared from an outbreak isolate effectively reduced mortality in turkeys [8]. Subunit vaccines based on PlpE multi-epitope proteins [26] and outer membrane vesicles displaying PlpE [27] have been developed. Flagellin enhances the immunogenicity of Lipoprotein E subunit vaccine [28]. Recombinant turkey herpesvirus expressing P. multocida OmpH protein has been evaluated for fowl cholera prevention in ducks [29]. Attenuation through serial passage yielded a candidate vaccine strain PMZ8 with protective efficacy in ducks [30]. A truncated LPS mutant strain also induced protective immunity in ducks [31]. Adjuvants significantly influence the immunogenicity of bacterin vaccines [32].

For a detailed comparison of vaccine types and administration protocols, refer to the article Fowl Cholera Vaccine: Types, Efficacy, and Administration in Poultry.

Antimicrobial resistance management

Rational use of antimicrobials and routine surveillance of resistance patterns are critical to preserve treatment options [19, 6, 10]. Genomic characterization of resistance determinants helps guide therapy [19].

Conclusion

Avian cholera remains a major threat to poultry and wild bird populations worldwide. Advances in molecular diagnostics, genomics, and vaccinology continue to refine our understanding of fowl cholera bacterial pathogenesis and improve control strategies [30, 17, 16, 7]. Integrated management combining biosecurity, vaccination, and prudent antimicrobial use is essential for sustainable disease control.

For additional information on related topics, consult Avian Cholera (Fowl Cholera): Etiology, Pathogenesis, and Control, Avian Pasteurellosis (Fowl Cholera) in Poultry, and Avian Cholera in Waterfowl.

References

[1] Yan D, Xu G, Cheng Y, et al. Pasteurella multocida causes liver pyroptosis in broilers through the MAPK-NLRP3-GSDMD signaling pathway. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42139792/

[2] Miller I, Jerry C, Nguyen V, et al. 100% Mortality in commercial slow-growing broiler chickens with acute fowl cholera. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40643942/

[3] Gornatti-Churria CD, Jerry C, Ramsubeik S, et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026. https://pubmed.ncbi.nlm.nih.gov/40996859/

[4] Taylor HS, Foxwell J, Jauregui R, et al. Pasteurella multocida infections in yellow-eyed penguins (Hoiho; Megadyptes antipodes) in Otago, New Zealand: case series of mortalities due to avian cholera. J Wildl Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40294904/

[5] Cai Q, Li Y, Chang YF, et al. Pasteurella multocida causes liver injury in ducks by mediating inflammatory, apoptotic and autophagic pathways. Microb Pathog. 2023. https://pubmed.ncbi.nlm.nih.gov/37683832/

[6] El-Tarabili RM, Enany ME, Alenzi AM, et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/39948418/

[7] Hashish A, Johnson TJ, Ghanem M, et al. Complete genome sequences of eight Pasteurella multocida isolates representing all lipopolysaccharide outer core loci. Microbiol Resour Announc. 2024. https://pubmed.ncbi.nlm.nih.gov/39365089/

[8] Semmate N, Bamouh Z, Elkarhat Z, et al. Isolation and characterization of Pasteurella multocida A from an outbreak in turkeys in Morocco and vaccine preparation and evaluation. Avian Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40643939/

[9] Omaleki L, Blackall PJ, Cuddihy T, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022. https://pubmed.ncbi.nlm.nih.gov/35266868/

[10] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021. https://pubmed.ncbi.nlm.nih.gov/34840474/

[11] Allen JL, Bushell RN, Noormohammadi AH, et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/38228079/

[12] Gao P, Wang L, Wang S, et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024. https://pubmed.ncbi.nlm.nih.gov/38960217/

[13] Dassanayake RP, Briggs RE, Kaplan BS, et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/40140814/

[14] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. Br Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/40960429/

[15] Xiao J, Li Y, Hu Z, et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021. https://pubmed.ncbi.nlm.nih.gov/34534643/

[16] Poussard M, Pant SD, Huang J, et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025. https://pubmed.ncbi.nlm.nih.gov/39448061/

[17] Beyene D, Shite A, Getachew B. Development and optimization of in-house made indirect ELISA kit for the detection of antibodies against Pasteurella multocida in chicken. BMC Immunol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724974/

[18] Smith E, Miller E, Aguayo JM, et al. Genomic diversity and molecular epidemiology of Pasteurella multocida. PLoS One. 2021. https://pubmed.ncbi.nlm.nih.gov/33822782/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[19] Miao F, Dai B, Li Z, et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41637789/

[20] Chen H, Jiang N, Fu G, et al. Characterization and potential application of phage vB_PmuM_CFP3 for phage therapy against avian Pasteurella multocida. Animals (Basel). 2024. https://pubmed.ncbi.nlm.nih.gov/39595321/

[21] Wahdan A, Elsebai MF, Elhaig MM, et al. Innovative use of wild Egyptian artichoke extract to control fowl cholera in vitro. Vet World. 2025. https://pubmed.ncbi.nlm.nih.gov/40182829/

[22] Reuben RC, Sarkar SL, Ibnat H, et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Sci Rep. 2021. https://pubmed.ncbi.nlm.nih.gov/33903662/

[23] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025. https://pubmed.ncbi.nlm.nih.gov/40103817/

[24] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-irradiated fowl cholera mucosal vaccine: potential vaccine candidate for safe and effective immunization of chicken against fowl cholera. Front Immunol. 2021. https://pubmed.ncbi.nlm.nih.gov/34917086/

[25] Chen J, Sun Y, Hu Y, et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025. https://pubmed.ncbi.nlm.nih.gov/40934985/

[26] Xiang X, Sun Y, Zhang H, et al. Evaluation of immunoprotective effects of PlpE multi-epitope protein incorporated within the aluminum hydroxide-adjuvanted inactivated vaccine against Pasteurella multocida infection in chickens. Poult Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40561824/

[27] Li Y, Chen L, Xiao J, et al. Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida. Vaccine. 2025. https://pubmed.ncbi.nlm.nih.gov/39603075/

[28] Chung YC, Cheng LT, Chu CY, et al. Flagellin enhances the immunogenicity of Pasteurella multocida lipoprotein E subunit vaccine. Avian Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/39400212/

[29] Apinda N, Yao Y, Zhang Y, et al. Efficiency of NHEJ-CRISPR/Cas9 and Cre-LoxP engineered recombinant turkey herpesvirus expressing Pasteurella multocida OmpH protein for fowl cholera prevention in ducks. Vaccines (Basel). 2023. https://pubmed.ncbi.nlm.nih.gov/37766174/

[30] Ji X, Meng Y, Yang H, et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41747463/

[31] Zhao X, Yang F, Shen H, et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022. https://pubmed.ncbi.nlm.nih.gov/35236414/

[32] Ghadimipour R, Ghorbanpoor M, Gharibi D, et al. Effects of selected adjuvants on immunogenicity and protectivity of Pasteurella multocida bacterin vaccine in chickens. Arch Razi Inst. 2021. https://pubmed.ncbi.nlm.nih.gov/35096310/

[33] Li Y, Xiao J, Chang YF, et al. Immunogenicity and protective efficacy of the recombinant Pasteurella multocida lipoproteins VacJ and PlpE, and outer membrane protein H from P. multocida A:1 in ducks. Front Immunol. 2022. https://pubmed.ncbi.nlm.nih.gov/36275745/

[34] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021. https://pubmed.ncbi.nlm.nih.gov/34554268/

[35] Kannaki TR, Priyanka E, Haunshi S. Research Note: Disease tolerance/resistance and host immune response to experimental infection with Pasteurella multocida A:1 isolate in Indian native Nicobari chicken breed. Poult Sci. 2021. https://pubmed.ncbi.nlm.nih.gov/34217907/